#USA #New York #Securities Fraud #Pomerantz LLP #GoHealth

Investigation of GoHealth, Inc. by Pomerantz LLP

The Pomerantz Law Firm has recently initiated an investigation concerning allegations of securities fraud involving GoHealth, Inc. (NASDAQ: GOCO). This investigation is aimed at protecting the interests of the company’s investors after serious claims have arisen regarding its business practices.

On May 1, 2025, the U.S. Department of Justice (DOJ) filed a False Claims Act complaint against several health insurance entities, including GoHealth. The complaint accuses these companies of engaging in illegal activities by paying substantial kickbacks to brokerage firms as an incentive for enrollments into their Medicare Advantage plans. The DOJ claims that these unlawful payments occurred from 2016 through at least 2021, amounting to hundreds of millions of dollars.

The consequences of this announcement were immediate, reflecting the market's reaction to potential legal repercussions. Following the news of the lawsuit, GoHealth's stock plummeted by $1.09 per share—about 10.35%—closing at just $9.44. Such a decline highlights the market’s apprehension regarding both the impact of legal troubles and the broader implications for GoHealth’s operational integrity.

Pomerantz LLP, noted for its expertise in corporate, securities, and antitrust class actions, advises any investors concerned about their stakes in GoHealth to reach out. Danielle Peyton has been appointed as the contact point for inquiries, and investors are encouraged to explore their options during this unsettling time.

Founded by the pioneering attorney Abraham L. Pomerantz, who established much of the groundwork for securities class actions, the firm retains a long-standing tradition of advocating for investors. They have achieved numerous settlements that have favored victims of securities fraud and corporate misconduct, making it crucial for affected parties to engage with their investigation to protect their investments.

As this situation evolves, it is essential for investors to remain informed about developments and the potential consequences of the ongoing investigation. The firm continues to emphasize the importance of transparency and accountability in corporate practices, ensuring that investors' interests are represented effectively.

Ultimately, the investigation signifies a critical moment for GoHealth, Inc. and its investors as they navigate the complexities of potential financial and reputational damages stemming from these allegations. The resolution of this case could shape not only the future of GoHealth but also set precedents for compliance standards across the healthcare insurance industry. Investors are, therefore, encouraged to stay vigilant and proactive in seeking the appropriate legal counsel as they confront these pressing issues.

For further details or to discuss your potential claims, reach out to Pomerantz LLP.

Contact Information:

• - Danielle Peyton
• - Phone: 646-581-9980 ext. 7980
• - Email: [email protected]

This is an important moment for GoHealth investors to understand their rights and the recourse available to them in light of the unfolding investigation.